Biotek-snakken — Marts 2020
-
-
Kunne se ud til at Gilead's Remdesivir bliver første på markedet mod Corona virus. https://m.firstwordpharma.com/analysts-give-gileads-remdesivir-50-chance-success-covid-19-treatment
-
-
-
-
-
Ny storaktionærer i Hansa Biopharma: https://www.aktiespararna.se/analysguiden/article/726483
-
Test.
-
Keyed og LP90 - ja selvom vi fik en mavepumper den anden dag i Hansa BP så syntes jeg altså de har en god case når man tar de lange briller på. God kliniske resultater med Imlifidase, som vel ganske “sikkert” kommer til at lede til godkendelse i Europa og USA(usa2023) . Hvad der sker med kursen på den korte bane i disse coronatider det skal jeg ikke kloge i.
... -
China's coronavirus vaccine could be ready for trials next month
Chinese officials say that a coronavirus vaccine could be ready for clinical trials and emergency situations next month according to press reports.
pharmaphorum (pharmaphorum.com)
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind